| Name | N'-hydroxy-4-[5-[4-(2-methyl-5-propan-2-yl-1,3-thiazol-4-yl)phenoxy]pentoxy]benzenecarboximidamide |
|---|---|
| Synonyms |
dw-1350
unii-1cd2z2ggyn |
| Description | DW-1350 is a LTB4 receptor antagonist. |
|---|---|
| Related Catalog | |
| Target |
LTB4 |
| In Vitro | DW-1350 is a LTB4 receptor antagonist. DW-1350 shows inhibitory effects against osteoclast in terms of differentiation, formation, fusion and bone absorption[1]. |
| References |
| Molecular Formula | C25H31N3O3S |
|---|---|
| Molecular Weight | 453.59700 |
| Exact Mass | 453.20900 |
| PSA | 118.20000 |
| LogP | 6.66480 |
| Storage condition | 2-8℃ |